Intellipharmaceutics Corp.

CRX

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

DRUG DELIVERY ENGINE

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;DRUG DELIVERY;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

HYPERFOAM

Drug delivery systems, namely controlled, timed release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; drug delivery systems, namely controlled, timed release pharmaceutical compositions in the nature of oral solid dose tablets or capsules provided as an integral component of pharmaceutical preparations for humans;HYPER FOAM;Research and development services in the pharmaceutical and biological sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release pharmaceutical preparations for humans;

HYPERMATRIX

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;HYPER MATRIX;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIGITRANSPORTER

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT TRANSPORTER;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIGITRANSPORTER

INTELLIPHARMACEUTICS TRANSPORTER; INTELLIGENT PHARMACEUTICS TRANSPORTER;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIMATRIX

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT MATRIX;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIMATRIX

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT MATRIX;

INTELLIOSMOTICS

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT OSMOTICS;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIOSMOTICS

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIPELLETS

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT PELLETS;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIPELLETS

INTELLIGENT PELLETS;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIPHARMACEUTICS

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT PHARMACEUTICS;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLIPHARMACEUTICS

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT PHARMACEUTICS;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

INTELLISHUTTLE

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT SHUTTLE;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

OPODRAS

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

OXTENDA

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

OXTENDA HA

(Based on 44(e)) (Based on Intent to Use) Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;HA;(Based on 44(e)) (Based on Intent to Use) Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

OXTENDA HC

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;The wording OXTENDA HC has no meaning in a foreign language.;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

OXTENDA ODR

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;The wording OXTENDA ODR has no meaning in a foreign language.;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

OXYM

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis; none of the above for skin care or acne care;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

PODRAS

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;The wording PODRAS has no meaning in a foreign language.;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REGABATIN

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REGABATIN CRX

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;CRX;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REXISTA

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations;

REXISTA HC

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REXISTA HM

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;HM;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REXISTA MO

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparation;

REXISTA OC

Drug delivery systems, namely, drug delivery agents in the form of tablets, capsules, and pellets that provide controlled timed release and controlled targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, drug delivery agents in the form of oral solid dose tablets and capsules that provide controlled timed release and controlled targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, drug delivery agents in the form of tablets, capsules, and pellets for humans that provide controlled timed release and controlled targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;OC;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and targeted release pharmaceutical preparations;

REXISTA OXYC

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis; none of the above for skin care or acne care;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

REXISTA OXYM

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis; none of the above for skin care or acne care;Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;

SFT

Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, namely preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;Research and development services for others in the pharmaceutical sciences, namely the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;